Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age
Clinical trial NCT02610348 · COMPLETED
Trial details
- NCT number
- NCT02610348
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2015-12-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.